Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2018

Open Access 01-12-2018 | Research article

Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study

Authors: Naozumi Hashimoto, Akira Ando, Shingo Iwano, Koji Sakamoto, Shotaro Okachi, Asuka Matsuzaki, Yu Okada, Kenji Wakai, Kohei Yokoi, Yoshinori Hasegawa

Published in: BMC Pulmonary Medicine | Issue 1/2018

Login to get access

Abstract

Background

There is only limited information on the impact of thin-section computed tomography (TSCT)-determined usual interstitial pneumonia (UIP) pattern in the decision-making for resection in newly diagnosed lung cancer patients.

Methods

In this retrospective analysis, data were reviewed from 499 newly diagnosed lung cancer patients who received bronchoscopy between 2010 and 2014. The clinical impact of TSCT-determined UIP pattern on the decision-making process for resection in this cohort was evaluated.

Results

The prevalence rate of TSCT-determined fibrosis was 14.8% (74/499 cases), 86.5% (64/74 cases) of which also had TSCT-determined emphysema. The fibrosis group comprised 40 patients with possible UIP and 34 patients with the UIP pattern. Among surgical candidates, the number of surgeries performed was lower in the fibrosis group (60.8%) than in the normal and emphysema groups (84.7 and 77.3%, respectively). Although the proportion of possible UIP did not differ between surgical candidates and patients with resected lung cancer, the proportion of UIP pattern in patients with resected lung cancer was decreased by 8.5%, compared to the surgical candidates. Although measurement of diffusing capacity of the lung for carbon monoxide (DLCO) was performed in more than 97% of patients with thoracic surgery, only 58% of patients without thoracic surgery had DLCO measurement. Multivariate analysis showed that the finding of UIP pattern independently affects the decision-making process for thoracic surgery. The adjusted odds ratios for the comparison between the patients without fibrosis and the patients with UIP pattern was 0.266 (95% confidence intervals: 0.087–0.812).

Conclusions

The presence of TSCT-determined UIP pattern might independently affect the decision-making process for proposing thoracic surgery with curative intent.
Literature
1.
go back to reference Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37:95–101.CrossRefPubMed Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37:95–101.CrossRefPubMed
2.
go back to reference Matsuo M, Hashimoto N, Usami N, et al. Inspiratory capacity as a preoperative assessment of patients undergoing thoracic surgery. Interact Cardiovasc Thorac Surg. 2012;14:560–4.CrossRefPubMedPubMedCentral Matsuo M, Hashimoto N, Usami N, et al. Inspiratory capacity as a preoperative assessment of patients undergoing thoracic surgery. Interact Cardiovasc Thorac Surg. 2012;14:560–4.CrossRefPubMedPubMedCentral
3.
go back to reference Zhang J, Zhou JB, Lin XF, et al. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology. 2013;18:297–302.CrossRefPubMed Zhang J, Zhou JB, Lin XF, et al. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology. 2013;18:297–302.CrossRefPubMed
4.
go back to reference Osuka S, Hashimoto N, Sakamoto K, et al. Risk stratification by the lower limit of normal of FEV1/FVC for postoperative outcomes in patients with COPD undergoing thoracic surgery. Respir Investig. 2015;53:117–23.CrossRefPubMed Osuka S, Hashimoto N, Sakamoto K, et al. Risk stratification by the lower limit of normal of FEV1/FVC for postoperative outcomes in patients with COPD undergoing thoracic surgery. Respir Investig. 2015;53:117–23.CrossRefPubMed
5.
go back to reference Matsuzaki A, Hashimoto N, Okachi S, et al. Clinical impact of the lower limit of normal of FEV1/FVC on survival in lung cancer patients undergoing thoracic surgery. Respir Investig. 2016;54:184–92.CrossRefPubMed Matsuzaki A, Hashimoto N, Okachi S, et al. Clinical impact of the lower limit of normal of FEV1/FVC on survival in lung cancer patients undergoing thoracic surgery. Respir Investig. 2016;54:184–92.CrossRefPubMed
6.
go back to reference Hashimoto N, Matsuzaki A, Okada Y, et al. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients. BMC Pulm Med. 2014;14:14.CrossRefPubMedPubMedCentral Hashimoto N, Matsuzaki A, Okada Y, et al. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients. BMC Pulm Med. 2014;14:14.CrossRefPubMedPubMedCentral
7.
go back to reference Kitano M, Iwano S, Hashimoto N, et al. Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients. Int J Chron Obstruct Pulmon Dis. 2014;9:1347–56.PubMedPubMedCentral Kitano M, Iwano S, Hashimoto N, et al. Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients. Int J Chron Obstruct Pulmon Dis. 2014;9:1347–56.PubMedPubMedCentral
8.
go back to reference Ueda K, Jinbo M, Li TS, et al. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res. 2006;12:6730–6.CrossRefPubMed Ueda K, Jinbo M, Li TS, et al. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res. 2006;12:6730–6.CrossRefPubMed
9.
go back to reference Sato T, Teramukai S, Kondo H, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2013;147:1604–1611.e1603.CrossRefPubMed Sato T, Teramukai S, Kondo H, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2013;147:1604–1611.e1603.CrossRefPubMed
10.
go back to reference Voltolini L, Bongiolatti S, Luzzi L, et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. Eur J Cardiothorac Surg. 2013;43:e17–23.CrossRefPubMed Voltolini L, Bongiolatti S, Luzzi L, et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. Eur J Cardiothorac Surg. 2013;43:e17–23.CrossRefPubMed
11.
go back to reference Sato T, Watanabe A, Kondo H, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149:64–70 e62.CrossRefPubMed Sato T, Watanabe A, Kondo H, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149:64–70 e62.CrossRefPubMed
12.
go back to reference Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35:496–504.CrossRefPubMed Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35:496–504.CrossRefPubMed
13.
go back to reference Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.CrossRefPubMedPubMedCentral Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.CrossRefPubMedPubMedCentral
14.
go back to reference Hashimoto N, Iwano S, Kawaguchi K, et al. Impact of thin-section computed tomography-determined combined pulmonary fibrosis and emphysema on outcomes among patients with Resected lung cancer. Ann Thorac Surg. 2016;102:440–7.CrossRefPubMed Hashimoto N, Iwano S, Kawaguchi K, et al. Impact of thin-section computed tomography-determined combined pulmonary fibrosis and emphysema on outcomes among patients with Resected lung cancer. Ann Thorac Surg. 2016;102:440–7.CrossRefPubMed
15.
16.
go back to reference Woodruff PG, Agusti A, Roche N, et al. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385:1789–98.CrossRefPubMedPubMedCentral Woodruff PG, Agusti A, Roche N, et al. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385:1789–98.CrossRefPubMedPubMedCentral
17.
go back to reference Okachi S, Imai N, Imaizumi K, et al. Endobronchial ultrasound transbronchial needle aspiration in older people. Geriatr Gerontol Int. 2013;13:986–92.CrossRefPubMed Okachi S, Imai N, Imaizumi K, et al. Endobronchial ultrasound transbronchial needle aspiration in older people. Geriatr Gerontol Int. 2013;13:986–92.CrossRefPubMed
18.
go back to reference Okachi S, Imai N, Imaizumi K, et al. Factors affecting the diagnostic yield of Transbronchial biopsy using Endobronchial Ultrasonography with a guide sheath in peripheral lung cancer. Intern Med. 2016;55:1705–12.CrossRefPubMed Okachi S, Imai N, Imaizumi K, et al. Factors affecting the diagnostic yield of Transbronchial biopsy using Endobronchial Ultrasonography with a guide sheath in peripheral lung cancer. Intern Med. 2016;55:1705–12.CrossRefPubMed
19.
go back to reference Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.CrossRefPubMed Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.CrossRefPubMed
20.
21.
go back to reference Maeda R, Yoshida J, Ishii G, et al. The prognostic impact of cigarette smoking on patients with non-small cell lung cancer. J Thorac Oncol. 2011;6:735–42.CrossRefPubMed Maeda R, Yoshida J, Ishii G, et al. The prognostic impact of cigarette smoking on patients with non-small cell lung cancer. J Thorac Oncol. 2011;6:735–42.CrossRefPubMed
22.
go back to reference Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26:586–93.CrossRefPubMed Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26:586–93.CrossRefPubMed
23.
go back to reference Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–87.CrossRefPubMed Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–87.CrossRefPubMed
24.
25.
go back to reference Baldwin DR, White B, Schmidt-Hansen M, et al. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ. 2011;342:d2110.CrossRefPubMed Baldwin DR, White B, Schmidt-Hansen M, et al. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ. 2011;342:d2110.CrossRefPubMed
26.
go back to reference Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34:17–41.CrossRefPubMed Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34:17–41.CrossRefPubMed
27.
go back to reference Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003;168:531–7.CrossRefPubMed Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003;168:531–7.CrossRefPubMed
28.
go back to reference Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J. 2011;38:176–83.CrossRefPubMed Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J. 2011;38:176–83.CrossRefPubMed
29.
go back to reference Matsuo K, Iwano S, Okada T, et al. 3D-CT lung volumetry using multidetector row computed tomography: pulmonary function of each anatomic lobe. J Thorac Imaging. 2012;27:164–70.CrossRefPubMed Matsuo K, Iwano S, Okada T, et al. 3D-CT lung volumetry using multidetector row computed tomography: pulmonary function of each anatomic lobe. J Thorac Imaging. 2012;27:164–70.CrossRefPubMed
30.
go back to reference Kitaguchi Y, Fujimoto K, Hayashi R, et al. Annual changes in pulmonary function in combined pulmonary fibrosis and emphysema: over a 5-year follow-up. Respir Med. 2013;107:1986–92.CrossRefPubMed Kitaguchi Y, Fujimoto K, Hayashi R, et al. Annual changes in pulmonary function in combined pulmonary fibrosis and emphysema: over a 5-year follow-up. Respir Med. 2013;107:1986–92.CrossRefPubMed
31.
go back to reference Kim YS, Jin GY, Chae KJ, et al. Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema. Br J Radiol. 2015;88:20150545.CrossRefPubMedPubMedCentral Kim YS, Jin GY, Chae KJ, et al. Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema. Br J Radiol. 2015;88:20150545.CrossRefPubMedPubMedCentral
32.
go back to reference British Thoracic Society Society of Cardiothoracic Surgeons of Great Britain Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56:89–108. British Thoracic Society Society of Cardiothoracic Surgeons of Great Britain Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56:89–108.
33.
go back to reference Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.CrossRefPubMed
34.
go back to reference Deepak JA, Ng X, Feliciano J, et al. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12:742–51.CrossRefPubMedPubMedCentral Deepak JA, Ng X, Feliciano J, et al. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12:742–51.CrossRefPubMedPubMedCentral
Metadata
Title
Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study
Authors
Naozumi Hashimoto
Akira Ando
Shingo Iwano
Koji Sakamoto
Shotaro Okachi
Asuka Matsuzaki
Yu Okada
Kenji Wakai
Kohei Yokoi
Yoshinori Hasegawa
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2018
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-017-0565-5

Other articles of this Issue 1/2018

BMC Pulmonary Medicine 1/2018 Go to the issue